Biotech lead generation that finds decision-makers.
BeReach reads the public signals biotech and pharma companies leave behind, like funding rounds, clinical trial milestones, partnerships and hiring. It qualifies each company against your ICP, then helps you reach the right decision-maker with a warm, contextual message.
1,000+ teams4.9| # | Name | Conn | Signal |
|---|---|---|---|
| 1 |  Dr Helena Voss VP Clinical Development · Seralyn Bio | 2nd | Liked the post |
| 2 |  Nathan Frost Head of Business Development · Aximia Therapeutics | 2nd | Commented |
| 3 |  Priyanka Menon Director of R&D · Novexa Labs | 3rd | Commented |
| 4 | Oliver Grant Founder · Cellwave Bio | 2nd | Reposted |
| 5 | Sara Lindqvist Program Manager · Halden Pharma | 3rd | Liked the post |
Biotech and pharma signals
funding, trials, partnerships, hiring
Typical acceptance rate
warm, contextual first touch
Typical reply rate
vs generic cold outreach
To a qualified list
any modality, any stage
Your agent scans where biotech and pharma teams actually surface: funding rounds and who led them, phase progress in public trial registries, research and licensing announcements, clinical and regulatory job posts, and the people behind each program.
Every company is scored against your ideal profile on modality, trial phase, funding stage and hiring activity, so a preclinical shop and a Phase 2 team never land in the same list.
For each qualified company the agent finds the right clinical, regulatory or business development lead and helps you send a message that references a real milestone, like a readout or a new research partner, not a generic template.
Know exactly when a biotech raises, who led it, and how much. A freshly funded team is actively buying services, tools and partners, so you can reach them while the budget is fresh.
Phase progress and enrollment updates in public registries mark a program advancing. Reach clinical and operations leads while priorities and needs are shifting.
Research, licensing and co-development deals show a company opening up its stack. Lead with a reason tied to their newest partnership, not a cold pitch.
A company posting clinical, regulatory or business development roles is scaling a program. Track hiring to find teams in active growth mode.
Prefer to work in Claude?
BeReach runs as a connector inside Claude and Claude Cowork. Ask in plain language and it prospects, qualifies, and drafts your outreach, with every send waiting for your approval. See the Claude connector.
BeReach reads the public web in real time, across funding data, public clinical trial registries, partnership announcements, job boards and public profiles, then cross-references them to surface qualified companies along with the actual decision-maker's name and how to reach them. It is live signal, not a quarterly database dump.
Legacy databases index enterprise firmographics and refresh slowly, so early therapeutics startups and specialized services vendors are under-covered or missing entirely. BeReach searches the real-time sources where biotech and pharma companies actually surface, like funding, trial milestones, partnerships and hiring, so it finds accounts those databases do not have.
Yes. Every lead is built from public signals across the open web, including public trial registries, cross-referenced and verified. There is no scraping behind a login and no private database, and targeting is B2B, focused on business decision-makers.
Funding stage and recency, clinical trial phase and milestones, partnerships and licensing deals, headcount and hiring activity. You describe your ICP in plain language and the agent scores each company against it, so only the strong-fit ones reach you.
Yes, and that is the difference from a list tool. After the Finder surfaces companies and the Qualifier scores them, the Reacher helps you open a warm, multichannel conversation with the right person, referencing a real signal like a recent raise or a Phase 2 milestone instead of a generic template.
Yes. Just describe what you want, like a biotech that advanced to Phase 2 hiring a Head of Clinical Operations in the US, and the agent handles the combination of modality, phase, role and buying signals. No filters or boolean syntax to learn.
Usually under two minutes. Describe the companies you want, the agent scans the public sources, qualifies them against your ICP, and returns a list with named decision-makers ready to reach out to.
A job post is the least ambiguous buying signal on LinkedIn. Here is how to read hiring as intent across two motions, the company hiring for a role you enable and the champion who just changed jobs, with a signal-to-play map for each.
Alexandre Sarfati
Sales Navigator does not own the signal layer. Here are 12 LinkedIn intent signals, split into person and company triggers, each scored by how fast it decays, how strong it is, and what to send while it is still warm.
Alexandre Sarfati
Proxycurl was doing $10M/year on LinkedIn data. Then LinkedIn and Microsoft sued. Here's what the court cases actually say about LinkedIn data compliance, and the responsible approaches that work without the legal risk.
Alexandre Sarfati
Describe your ideal biotech or pharma account and let your agent find, qualify, and reach the decision-makers behind it.
Free credits inside · no credit card
Click a button and let your favorite AI weigh in.
